GlassScriptPhysician profile
Alice Wong
NPI 1497114268
$2,297.50
in general payments reported to CMS, 2019-2025
19 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.95 · 2022: $205 · 2023: $654 · 2024: $879 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,024 · Education: $40.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,024.10 |
| Education | $40.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $453.93 | 2023-2025 | Miebo, Envista Mx60 Iol, Xiidra |
| Abbvie INC. | $384.74 | 2022-2025 | Durysta |
| Regeneron Healthcare Solutions, INC. | $334.78 | 2023-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $265.63 | 2022-2024 | Rocklatan, Simbrinza, Rhopressa |
| Tarsus Pharmaceuticals, INC. | $172.47 | 2024-2025 | Xdemvy |
| Astellas Pharma US INC | $168.75 | 2023-2025 | Izervay |
| Oyster Point Pharma, INC. | $103.85 | 2023-2024 | Tyrvaya, Ryzumvi |
| Ani Pharmaceuticals, INC. | $92.15 | 2025 | Iluvien, Yutiq |
| Alimera Sciences, INC. | $67.48 | 2021-2024 | Iluvien, Yutiq |
| Novartis Pharmaceuticals Corporation | $50.53 | 2023 | |
| Spark Therapeutics, INC. | $37.12 | 2022 | |
| Sun Pharmaceutical Industries INC. | $35.26 | 2025 | |
| Harrow Eye, LLC | $25.26 | 2024 | |
| Rayner Intraocular Lenses Limited | $23.30 | 2023 | Rayone Spheric, Omidria, Rayone Emv |
| New World Medical,INC. | $19.49 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $18.41 | 2022 | |
| Biotissue Holdings INC. | $17.69 | 2025 | |
| Eyepoint US, INC. | $14.95 | 2022 | |
| Ge Healthcare | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.